Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeated Doses of PF-04958242 in Healthy Volunteers
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the safety, tolerability, and pharmacokinetics of PF-04958242 at a
number of ascending doses administered once daily for 14 days in healthy volunteers.